期刊文献+

透析患者磷管理的强化健康教育 被引量:5

下载PDF
导出
摘要 透析(包括血液透析和腹膜透析)是终末期肾脏病患者维持生存的常用方法,高磷血症是其常见并发症之一,我国透析患者血磷达标率仅为33%。长期高磷血症除了会引发继发性甲状旁腺功能亢进、矿物质和骨代谢异常之外,还是导致心脏瓣膜、血管和软组织转移性钙化的始动因素,也是透析患者死亡的独立危险因素。
出处 《浙江医学》 CAS 2016年第11期898-898,901,共2页 Zhejiang Medical Journal
  • 相关文献

参考文献10

  • 1Kendrick J, Chonchol M. The role of phosphorus in the develop- ment and progression of vascular calcification[J]. Am J Kidney Dis, 2011,58(5):826-834.
  • 2Palmer S C, Hayen A, Macaskill P, et al. Serum levels of phospho- rus,parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis[J]. JAMA, 2011,305(11): 1119-1127.
  • 3KDIGO CKD-MBD Work Group. KDIGO Clinical practice guide- line for the diagnosis,evaluation,prevention,and treatment of chronic kidney disease-mineral and bone disorder(CKD-MBD) [J].Kidney Int,2009,76(Suppl 113):s1-130.
  • 4姜鸿,徐志宏,张凌,宋韩明,李文歌.慢性肾脏病3~5期透析前患者矿物质及骨代谢紊乱的调查分析[J].中国血液净化,2012,11(7):360-364. 被引量:43
  • 5Granja C A, Juerfensen P, Finkelstein F O, et al. Phosphate bal- ance in peritoneal dialysis patients: role of ultrafiltration[J]. Contrib Nephrol,2009,163:198-205.
  • 6Sapir-Koren R, Livshits G. Bone mineralization and regulation of phosphate homeostasis[J].lBMS BoneKEy,2011,8(6):286-300.
  • 7邵宁俊,王德选,庄捷秋,潘敏,潘璐璐,周志宏,费锦萍,高依依,蔡晖.碳酸镧与醋酸钙治疗维持性透析患者高磷血症的比较研究[J].温州医学院学报,2015,45(7):484-487. 被引量:17
  • 8Locatelli F, Del Vecchio L, Vioio L, et al. Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease pa- tients on dialysis: a comparison of safety profiles[J]. Expert Opin Drug Saf,2014,13(5):551-561.
  • 9JIANG N, FANG W, GU A P, et al. Improving diet recipe and cooking methods attenuates hyperphosphatemia in patients un- dergoing peritoneal dialysis[J]. Nutr Metab Cardiovasc Dis, 2015, 25(9):846-852.
  • 10Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phos- phate, and the risk of mortality in a European haemodialysis population[J]. Nephrol Dial Transplant, 2011,26(6):1948-1955.

二级参考文献28

  • 1高玉春,李孜,唐晓红,刁骧(审校).碳酸镧治疗维持性血液透析患者高磷血症有效性和安全性的系统评价[J].中国循证医学杂志,2006,6(10):727-732. 被引量:12
  • 2Block GA,Port FK.Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in managementAmerican Journal of Kidney Diseases,2000.
  • 3Brown EM,MacLeod RJ.Extracellular calcium sensing and extracellular calcium signalingPhysiological Reviews,2001.
  • 4Goodman W G,Goldin J,Kuizon B D,et al.Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysisNew England Journal of Homeopathy,2000.
  • 5National Kidney Foundation.K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney diseaseAmerican Journal of Kidney Diseases,2003.
  • 6JA Vassalotti,J Uribarri,SC Chen.Trends in mineral metabolism: kidney early evaluation program (KEEP) and the national health and nutrition examination survey (NHANES) 1999–2004American Journal of Kidney Diseases,2008.
  • 7Gutierrez O,Isakova T,Rhee E,et al.Fibroblast growth factor- 23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney diseaseJournal of the American Society of Nephrology,2005.
  • 8Kestenbaum B,Sampson IN,Rudser KD, et al.Serum phosphate levels and mortality risk among people with chronic kidney diseaseJournal of the American Society of Nephrology,2005.
  • 9Guideline Working Group,Japanese Society for Dialysis Therapy.clinical practice guidline for management of secondary hyperparathyroidism in chronic dialysis patientsTherapeutic Apheresis and Dialysis,2008.
  • 10Sela-Brown A,Silver J,Brewer G,et al.Identification of AUF1as a parathyroid hormone mRNA3-untranslated region-binding protein that determines parathyroid hormone mRNA stabilityJournal of Biological Chemistry,2000.

共引文献58

同被引文献32

引证文献5

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部